Supporting Information

Similar documents
Table S1. X-ray data collection and refinement statistics

Supplementary Table 1. Data collection and refinement statistics (molecular replacement).

Supplementary Materials for

Structural Insights into HIV-1 Neutralization by Broadly Neutralizing Antibodies PG9 and PG16

Crystallization-grade After D After V3 cocktail. Time (s) Time (s) Time (s) Time (s) Time (s) Time (s)

Supplementary Figure 1 (previous page). EM analysis of full-length GCGR. (a) Exemplary tilt pair images of the GCGR mab23 complex acquired for Random

Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen

Supporting Information

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.

Supplementary Information for. Heavy chain-only IgG2b-llama antibody effects near-pan HIV-1 neutralization by

Biological Mass Spectrometry. April 30, 2014

P G K R P E W M G W L K P R G G A V N Y A R P L Q G R V T M T R D V Y S D T A F

172R 172K TAM-2/172R TAM-2/172K. AZT concentration [nm] AZT concentration [nm] MgCl 2 2.5K 2.5K 5K 2.5K 5K 2.5K K 5K 2.5K 5K 2.5K 50 2.

SUPPLEMENTARY INFORMATION FOR. (R)-Profens Are Substrate-Selective Inhibitors of Endocannabinoid Oxygenation. by COX-2

Supporting Information

Boosts Following Priming with gp120 DNA

SUPPLEMENTAL MATERIAL. UNC119 is required for G protein trafficking in sensory neurons

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood

Proteins? Protein function. Protein folding. Protein folding diseases. Protein interactions. Macromolecular assemblies. The end product of Genes

Supplementary Information Janssen et al.

Chapter 3. Structure of Enzymes. Enzyme Engineering

Supplementary Materials for

Supplemental Information. An Atlas of b-glucuronidases. in the Human Intestinal Microbiome

Antigen Receptor Structures October 14, Ram Savan

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION (SI) FIGURES AND TABLES

Characterizing the mesophase behavior of hydrated 9.9 MAG at 20 C and at increasing concentrations of DDM by SAXS.

FCC2 5CY7 FCC1 5CY8. Actinonin 5CVQ

Atypical Natural Killer T-cell receptor recognition of CD1d-lipid antigens supplementary Information.

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

Supplementary Table 1. Properties of lysates of E. coli strains expressing CcLpxI point mutants

The Immunoassay Guide to Successful Mass Spectrometry. Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013

SUPPLEMENTARY INFORMATION

Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein

Supplementary information. Early development of broad neutralizing antibodies in HIV-1 infected infants

Chapter 6. X-ray structure analysis of D30N tethered HIV-1 protease. dimer/saquinavir complex

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

Supplementary Figure-1. SDS PAGE analysis of purified designed carbonic anhydrase enzymes. M1-M4 shown in lanes 1-4, respectively, with molecular

2005 LANDES BIOSCIENCE. DO NOT DISTRIBUTE.

Supplementary Materials for

SUPPLEMENTAL INFORMATION. Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays

Please check the slides

T cell Receptor. Chapter 9. Comparison of TCR αβ T cells

Structure of the measles virus hemagglutinin bound to the CD46 receptor. César Santiago, María L. Celma, Thilo Stehle and José M.

Figure S1. HP1α localizes to centromeres in mitosis and interacts with INCENP. (A&B) HeLa

Separation of Macrocyclic Lactones (Avermectins) on FLARE C18 MM & FLARE C18+ Columns

Organic Chemistry Laboratory Fall Lecture 3 Gas Chromatography and Mass Spectrometry June

Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody Responses

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points.

Probing the Potential Glycoprotein Binding Site of Sindbis Virus Capsid Protein With Dioxane and Model Building

Supporting Information Parsimonious Charge Deconvolution for Native Mass Spectrometry

High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies. R. J. Rose, E. Damoc, E. Denisov, A. Makarov, A. J. R.

Key Words: Brassica oleraceae, glucosinolate, liquid chromatography mass spectrometry, FNH-I-003

HIV Anti-HIV Neutralizing Antibodies

Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies

Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity

Mass Spectrometry. Mass spectrometer MALDI-TOF ESI/MS/MS. Basic components. Ionization source Mass analyzer Detector

Self-organization of dipyridylcalix[4]pyrrole into a supramolecular cage for dicarboxylates

Quantitative LC-MS/MS Analysis of Glucagon. Veniamin Lapko, Ph.D June 21, 2011

Summary Chapter 8 CHAPTER 8. Summary. Page 173

A pillar[2]arene[3]hydroquinone which can self-assemble to a molecular zipper in the solid state

In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes

This PDF file includes: Supplementary Figures 1 to 6 Supplementary Tables 1 to 2 Supplementary Methods Supplementary References

In situ proteolysis for protein crystallization and structure determination

An#body structure & func#on

Analysis of Uncomplexed and Copper-complexed Methanobactin with UV/Visible Spectrophotometry, Mass Spectrometry and NMR Spectrometry

Supplementary information. macrophages in foam cells

Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1

2D-LC as an Automated Desalting Tool for MSD Analysis

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Supplementary Materials for

A New HILIC/RP Mixed-Mode Column and Its Applications in Surfactant Analysis

Identification of Haemoglobinopathies by LC/MS

TEMA 5. ANTICUERPOS Y SUS RECEPTORES

(B D) Three views of the final refined 2Fo-Fc electron density map of the Vpr (red)-ung2 (green) interacting region, contoured at 1.4σ.

Transient β-hairpin Formation in α-synuclein Monomer Revealed by Coarse-grained Molecular Dynamics Simulation

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Characterization of an Unknown Compound Using the LTQ Orbitrap

Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation

UV Tracer TM Maleimide NHS ester

CS612 - Algorithms in Bioinformatics

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection

Glycosylation of the ENV Spike of Primate Immunodeficiency Viruses and Antibody Neutralization

HIV Neutralization Assays: p24 PBMC Assays as Compared with the Pseudovirus (TZM-bl) Assay Using Multiple HIV-1 Subtypes

HIV-1 glycan density drives the persistence of the mannose patch within an infected. Running title: Longitudinal persistence of the HIV mannose patch

Table S1: Kinetic parameters of drug and substrate binding to wild type and HIV-1 protease variants. Data adapted from Ref. 6 in main text.

Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12.

Antibodies are essential for the success of most vaccines (1),

Electronic Supplementary Information (ESI) for the article entitled:

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

SUPPLEMENTARY INFORMATION

Data are contained in multiple tabs in Excel spreadsheets and in CSV files.

SUPPLEMENTAL INFORMATION

Supporting Information

Challenges in Designing HIV Env Immunogens for Developing a Vaccine

Designer Cannabinoids

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data

AIDSVaccine2010 Atlanta, Georgia Willy Bogers. NIH HIVRad Grant nr 5P01AI066287

The Stura Footprint Combination HT-96 MD1-43 Rapidly analyse the crystallization potential of your protein and protein complexes.

Transcription:

Supporting Information Guan et al. 10.1073/pnas.1217609110 Fig. S1. Three patterns of reactivity for CD4-induced (CD4i) mabs. The following representative ELISAs show three patterns of reactivity for CD4i mabs. Note that none of the mabs bind trimeric HIV-1 envelope glycoprotein (Env), SOSIP. ELISAs were carried out as described in Materials and Methods for the mabs listed in Table 1. Pattern 1: mabs that exhibit 10- to 30-fold preferences for binding gp120-cd4 complexes over monomeric gp120. mab N12-i3 is the example. The following mabs from Table 1 exhibit this pattern: cluster A, L9-i1 and N12-i3; unassigned, N10-i6.1. Pattern 2: mabs that exhibit >30-fold preferences for binding of gp120-cd4 complexes over monomeric gp120. mab N12-i2 is the example. The following mabs from Table 1 exhibit this pattern: cluster A, N5-i5 and L9-i2; cluster C.1, N5-i1, N5-i3, N5-i4, N10-i1.1, N10-i5.3, N12-i1, N12-i2, N12-i4, N12-i5, N12-i7, N12-i8, and L9-i3; cluster C.2, N12-i10, N12-i17, N12-i18, and N12-i19; cluster C.3, N5-i2, N5-i6, N5-i14, N5-i7, N5-i12, N10-i3.1, and N12-i12; cluster C.4, N12-i14 and N5-i13; unassigned, N10-i4. Pattern 3: mabs that are strictly specific for gp120-cd4 complexes. mab N12-i15 is the example. The following mabs from Table 1 exhibit this pattern: cluster A, N26-i1; cluster B, N12-i15; cluster C.1, N5-i8; cluster C.3, N5-i9, N12-i9, and N12-i11; cluster C.4, L9-i4, N5-i10, N10-i2, and N12-i16. Fig. S2. Epitope mapping of the cluster B mab N12-i15. (A) mab competition ELISA using a limiting concentration of biotinylated N12-i15 and known CD4i mabs recognizing coreceptor binding site (CoRBS) epitopes 17b, 48d, E51, 412d, and IgGm9 (X5 derivative)] or a cluster A epitope, A32. (B) Deletion mutant mapping for N12-i15 by ELISA using full-length single-chain gp120-cd4 monomer (FLSC), FLSC-ΔV3, FLSC-ΔV1/ΔV2, or FLSC-ΔV3, ΔV1/ΔV2/ΔV3 and control mabs 17b (CoRBS) or b12 (CD4-binding site, CD4bs). (C) The I420R mutation in gp120 alters binding of N12-i15 to gp120-cd4 complexes. mabs 17b (CoRBS specific) and N12-03.1 (V3 specific) were used as positive controls. 1of6

Fig. S3. Stereo view of superimposed symmetry-related antigen-binding fragment (Fab) molecules present in the asymmetric unit of crystals of Fab A32, Fab N5-i5, and Fab N12-i15. Cα traces are shown as ribbons. A32: Fab A32 crystallized in the triclinic space group P1 with two Fabs (referred as Fab and Fab2 )in the asymmetric unit. Residue segment SKS 130H of the heavy chain constant region (C H ) of Fab1 and GGSSSS H31 of the variable heavy chain (V H ) of Fab2 were poorly accountable in the electron densities and were omitted in the final model. Two structurally independent Fab A32 molecules are highly similar, with an rmsd of Cα superimposition for the entire molecule of 0.82 Å and the variable (V) region of 0.75 Å. N5-i5: Fab N5-i5 formed crystals in monoclinic space group P2 1 which contained four Fabs in the asymmetric unit. The densities of each of four copies were very well defined with one residue segment of the C H (residues SSKSTSGG H134 ) missing in each copy and omitted in the final refinement. Pairwise superposition of Fab molecules present in the asymmetric unit of crystal yielded Cα rmds values for all atoms ranging between 0.51 and 1.10 Å and a V domain of 0.21 0.31 Å. N12-i15: Crystals of Fab N12-i15 were indexed in space group P4 3 and contained four Fab molecules per asymmetric unit. Three Fab molecules were well defined with few residue segments of the constant regions disordered and excluded from the final model (SSKSTSGG H134 of Fab1, Fab2 and Fab3; residues GTQ H191 of Fab2 and Fab3; and residues KVD L150 of Fab3). In contrast, entire constant region of the fourth Fab molecule was insufficiently ordered, with several residues characterized by poorly defined electron density. These residues were omitted in building the final model. Pairwise superposition of Fab molecules present in the asymmetric unit of crystal N12-i15 yielded Cα rmds values for all atoms in a range of 0.34 1.0 Å and a V domain of 0.23 0.35 Å. N12-i2: The hexagonal crystals of Fab N12-i2 were indexed in space group Legend continued on following page 2of6

P6 1 22 and contained one Fab molecule per asymmetric unit (not shown). Residues SYYEPGTSYH 100h of the complementarity-determining region (CDR) H3 loop and residues SSKSTSGG H134 and G H157 of the C H region were disordered and therefore were excluded from the final model. In addition some solvent-exposed regions of the C H and light change constant region (C L ) were weakly ordered as indicated by poorly defined electron density. Fig. S4. Tyrosine sulfation of N12-i2 CDR H3 C 4 reversed-phase (RP)-HPLC and electrospray ionization mass spectrometry (ESI-MS) analysis of purified N12-i2 Fab. Protein was analyzed on a Symmetry 300 C 4 column (2.1 150 mm, 3.5 μm) using a linear gradient of 5 65% of acetonitrile at a flow rate of 0.25 ml/min over 30 min. Deconvoluted ESI mass spectra are shown for a C 4 RP-HPLC elution peak. ESI-MS identified three protein components with masses corresponding to nonsulfated (49,014 Da), singly sulfated (49,096 Da) and doubly sulfated (49,173 Da) Fab N12-i2. Determined molecular masses are in agreement with expected values calculated based on the average isotope compositions of the oxidized form which include four intrachain and one interchain disulfide bonds (49,013; 49,094, and 49,174 Da, respectively). A presence of one sulfogroup corresponds to a +80 change in mass. 3of6

Table S1. Neutralization by CD4i mabs IC 50 titer in TZM-bl cells (ug/ml) Tier 1 Clade B Tier 1 Clade A Tier 1 Clade C Tier 2 Clade B Negative control Epitope cluster mab SF162 BaL.26 SS1196.1 DJ263.8 MS208.A1 MW965.26 TV1.1 6535.3 QH0692.42 THRO4156.18 REJO4541.58 WITO4160.33 MuLV HIV2+sCD4 Cluster A L9-i1 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N5-i5 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 L9-i2 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N12-i3 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N26-i1 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 Cluster B N12-i15 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 Cluster C.1 N5-i1 1.1 >50 13.8 >50 >50 0.9 >50 >50 3.9 >50 >50 >50 >50 >50 N5-i3 1 21.7 5.3 >50 >50 0.9 >50 >50 >50 >50 >50 >50 >50 >50 N5-i4 1.4 44 15.5 >50 >50 0.3 >50 >50 4.2 >50 >50 >50 >50 >50 N10-i1.1 0.86 10.5 10.9 >50 >50 9.5 >50 >50 >50 >50 >50 >50 >50 >50 N10-i5.3 3.2 29.1 10 44.7 >50 0.07 >50 >50 35.8 >50 >50 >50 >50 >50 N12-i1 1.8 40.2 16.9 47.7 >50 0.2 >50 >50 5.8 >50 >50 >50 >50 >50 N12-i2 1 11.6 8.9 >50 >50 0.08 >50 >50 5 >50 >50 >50 >50 9 N12-i4 1.7 38.7 40.3 >50 >50 7.3 >50 >50 21.3 >50 >50 >50 >50 <0.1 N12-i5 3.8 >50 39.6 >50 >50 0.2 >50 >50 >50 >50 >50 >50 >50 >50 N12-i7 1.6 32.1 32.1 >50 >50 1.1 >50 >50 17.8 >50 >50 >50 >50 >50 N12-i8 3.1 >50 39.4 >50 >50 0.5 >50 >50 >50 >50 >50 >50 >50 >50 L9-i3 1.7 30.1 15.5 >50 >50 >50 >50 >50 3 20.2 >50 >50 >50 >50 N5-i8 2.6 31.6 22.4 >50 >50 0.2 >50 >50 >50 >50 >50 >50 >50 >50 Cluster C.2 N12-i10 7.3 >50 >50 >50 >50 3.1 >50 ND ND ND ND >50 >50 >50 N12-i17 3.5 41.4 25.3 >50 >50 0.1 >50 >50 >50 >50 >50 >50 >50 >50 N12-i18 2.4 >50 40.8 >50 >50 0.3 >50 >50 9.2 >50 >50 >50 >50 >50 N12-i19 2.3 >50 41.1 >50 >50 0.3 >50 >50 20.5 >50 >50 >50 >50 >50 Cluster C.3 N5-i2 27.7 >50 >50 >50 >50 9.3 >50 >50 >50 >50 >50 >50 >50 >50 N5-i6 3.2 46 24.2 >50 >50 13.4 >50 >50 >50 >50 >50 >50 >50 >50 N5-i14 5.3 >50 27.8 >50 >50 0.6 >50 >50 >50 >50 >50 >50 >50 >50 N5-i7 4.2 >50 19.3 >50 >50 0.5 >50 >50 >50 >50 >50 >50 >50 >50 N5-i12 42.2 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N10-i3.1 3.1 34.9 22.4 >50 >50 0.08 >50 >50 >50 >50 >50 >50 >50 >50 N12-i12 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N5-i9 3.9 48.8 22.3 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N12-i9 3.2 46.6 >50 >50 >50 9.5 >50 >50 >50 >50 >50 >50 >50 >50 N12-i11 36.1 >50 >50 >50 >50 49.4 >50 >50 >50 >50 >50 >50 >50 >50 Cluster C.4 L9-i4 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N12-i14 1.3 38.8 20 >50 >50 >50 >50 >50 13.8 >50 >50 >50 >50 >50 N5-i10.1 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N10-i2 12.7 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N5-i13 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N12-i16 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 Unassigned N10-i4 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 N10-i6.1 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 4of6

Table S1. Cont. IC 50 titer in TZM-bl cells (ug/ml) Tier 1 Clade B Tier 1 Clade A Tier 1 Clade C Tier 2 Clade B Negative control Epitope cluster mab SF162 BaL.26 SS1196.1 DJ263.8 MS208.A1 MW965.26 TV1.1 6535.3 QH0692.42 THRO4156.18 REJO4541.58 WITO4160.33 MuLV HIV2+sCD4 Controls C11 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 A32 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 17b 8.5 39.8 26.9 >50 >50 0.3 >50 >50 6.2 >50 >50 >50 >50 <0.1 19e >5 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 >50 <0.1 b12 0.09 0.07 1.9 >50 0.7 <0.02 >50 7.3 0.3 2.5 6.4 25.1 >50 >50 Neutralization was carried out as described in Materials and Methods using HIV-1 or HIV-2 pseudoviruses. ND, not done. 5of6

Table S2. Data collection and refinement statistics Crystal A32 Fab N5-i5 Fab N12-i15 Fab N12-i2 Fab Data collection Wavelength ( Å) 1.00 1.00 0.98 0.98 Space group P1 P2 1 P4 3 P6 1 22 Cell parameters a, b, c (Å) 40.8, 71.3, 77.7 73.4, 84.5, 143.1 125.1, 125.1, 149.9 78.9, 78.9, 315.2 α, β, γ ( ) 103.7, 104.0, 105.4 90, 101, 90 90, 90, 90 90, 90, 120 Molecules (a.u.) 2 4 4 1 Resolution (Å) 50 1.85 (1.88 1.85) 50 1.95 (1.98 1.95) 50 2.59 (2.68 2.59) 50 1.95 (2.02 1.95) Number of reflections Total 117,353 232,588 256,664 200,085 Unique 59,060 123,808 71,607 43,782 R merg (%)* 12.0 (90.3) 11.3 (76.5) 14.5 (78.3) 9.4 (79.5) I/σ 17.9 (1.5) 12.7 (2.0) 16.3 (2.7) 54.6 (2.5) Completeness (%) 90.0 (89.5) 98.5 (98.7) 100.0 (99.9) 99.9 (99.7) Redundancy 3.8 (3.6) 3.5 (3.4) 20.2 (15.2) 7.6 (7.5) Refinement statistics Resolution, Å 36 1.85 20 1.95 20 2.6 20 1.95 R(%) 18.7 19.8 21.6 20.3 R free (%) 23.2 24.5 25.4 23.6 Number of atoms Protein 6,454 13,436 12,840 3,265 Water 355 802 566 298 Ligand/Ion 7 62 49 0 Overall B value (Å 2 ) Variable domain 37.1 36.0 33.0 38.4 Constant domain 36.5 40.7 40.6 46.3 Water 29.6 40.2 37.5 41.3 rmsd Bond lengths (Å) 0.017 0.019 0.019 0.020 Bond angles ( ) 1.5 1.7 1.8 1.8 Ramachandran Favored (%) 95.5 96.8 95.5 97.4 Allowed (%) 4.3 3.0 3.9 2.4 Outliers (%) 0.2 0.2 0.6 0.2 Protein Data Bank code 3TNM 3TNN 3QEH 3QEG All data outer shell. Values in parentheses are for highest-resolution shell. a.u., arbitrary units. *Rmerge = I - <I> / I, where I is the observed intensity and <I> is the average intensity obtained from multiple observations of symmetry-related reflections after rejections. R = F o - F c / F o, where F o and F c are the observed and calculated structure factors, respectively. R free defined by Brünger (1). Calculated with MolProbity (2). 1. Brunger AT (1992) Free R value: A novel statistical quantity for assessing the accuracy of crystal structures. Nature 355(6359):472 475. 2. Chen VB, et al. (2010) MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66(Pt 1):12 21. Table S3. Crystallization conditions Fab A32 N5-i5 N12-i15 N12-i2 Protein concentration Crystallization conditions 12 mg/ml 10 mg/ml 8 mg/ml 10 mg/ml 20% PEG 4000, 0.1 M Hepes, ph 7.5, 10% 2-propanol 30% PEG 4000, 0.2 M ammonium sulfate 2.2% PEG 400, 2 M ammonium sulfate, 0.1 M Hepes, 0.2 ph 7.5 20% wt/vol PEG 2,000, monomethyl ether. 0.01 M nickel (II) chloride hexahydrate, 0.1 M Tris HCl, 0.02 ph 8.5 6of6